Tempest Therapeutics (TPST) Gross Margin (2015 - 2018)
Tempest Therapeutics (TPST) reported Gross Margin of 20.00% for Q3 2018, down 28.21 percentage points from 48.21% a year earlier and down 13.33 percentage points from the prior quarter.
Powered by 
Analysis
Tempest Therapeutics (TPST) Gross Margin (2015 - 2018) Analysis & Trends
Over the twelve months ended Sep 30, 2018, Tempest Therapeutics' Gross Margin came in at -45.58%, up 473.25 percentage points year-over-year; for FY2017, it was -167.80%, up 559.31 percentage points from FY2016.
- By year, Gross Margin came in at -727.11% in FY2016 (-15.19 pp) and -711.91% in FY2015.
- Five-year quarterly Gross Margin spans a low of -1153.33% in Q3 2015 and a high of 48.21% in Q3 2017.
- Year over year, Gross Margin gained in six of the last eight quarters, with an average year-over-year change of +304.18 percentage points.
- The high point for year-over-year Gross Margin in five years was Q4 2017 (a gain of 944.74 percentage points); the low point was Q1 2016 (a drop of 572.15 percentage points).
- Per Business Quant data, the three quarters before Q3 2018 came in at 33.33% (Q2 2018), -67.16% (Q1 2018) and -139.56% (Q4 2017).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 68.19% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 74.74% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 73.54% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 78.02% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 83.60% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 72.04% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 79.76% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 72.78% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 85.33% |
| 10 | Tempest Therapeutics | 4.09 Mn | -26.23 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2018 | 20.00% |
| Jun 30, 2018 | 33.33% |
| Mar 31, 2018 | -67.16% |
| Dec 31, 2017 | -139.56% |
| Sep 30, 2017 | 48.21% |
| Jun 30, 2017 | -226.19% |
| Mar 31, 2017 | -326.98% |
| Dec 31, 2016 | -1,084.30% |
| Sep 30, 2016 | -691.37% |
| Jun 30, 2016 | -552.38% |
| Mar 31, 2016 | -705.48% |
| Dec 31, 2015 | -637.58% |
| Sep 30, 2015 | -1,153.33% |
| Jun 30, 2015 | -286.67% |
| Mar 31, 2015 | -133.33% |
API Access
Tempest Therapeutics Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=TPST&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "TPST", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=TPST&period=max&api_key=YOUR_API_KEY");
const data = await res.json();